These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 3513812)
1. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma. Guy K; Krajewski AS; Dewar AE Br J Cancer; 1986 Feb; 53(2):161-73. PubMed ID: 3513812 [TBL] [Abstract][Full Text] [Related]
2. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate. Guy K; Meehan RR; Dewar AE; Larhammar D Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424 [TBL] [Abstract][Full Text] [Related]
3. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia. Guy K; Docherty LJ; Dewar AE Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060 [TBL] [Abstract][Full Text] [Related]
4. Leu-10 (HLA-DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA-DR expression. Al-Katib A; Koziner B Br J Haematol; 1984 Jul; 57(3):373-82. PubMed ID: 6378248 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells. Pesando JM; Graf L J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of MHC class II antigens in chronic B-cell disorders. Drexler HG; Gignac SM; Brenner MK; Coustan-Smith E; Janossy G; Hoffbrand AV Clin Exp Immunol; 1988 Feb; 71(2):217-23. PubMed ID: 2450706 [TBL] [Abstract][Full Text] [Related]
7. [Immunodiagnosis of chronic lymphatic leukemia and leukemic non-Hodgkin's lymphoma with the monoclonal antibodies BL-Ig-L/1, BL-DR/1 and BL-T2]. Malberg K; Fischer H; Elendt D; Wutke K; Fiebig H Arch Geschwulstforsch; 1984; 54(4):325-32. PubMed ID: 6437368 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients. Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327 [TBL] [Abstract][Full Text] [Related]
9. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4). Hashimi L; Wang CY; Al-Katib A; Koziner B Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065 [TBL] [Abstract][Full Text] [Related]
10. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line. Pesando JM; Graf L; Hoffman P J Immunol; 1986 Sep; 137(6):1932-6. PubMed ID: 3489045 [TBL] [Abstract][Full Text] [Related]
11. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies. Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression. Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas. Krajewski AS; Guy K; Dewar AE; Cossar D J Pathol; 1985 Feb; 145(2):185-94. PubMed ID: 2579225 [TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma. Smith ME; Holgate CS; Williamson JM; Grigor I; Quirke P; Bird CC J Clin Pathol; 1987 Jan; 40(1):34-41. PubMed ID: 3546388 [TBL] [Abstract][Full Text] [Related]
15. An antigen common to chronic lymphocytic and hairy cell leukemia cells not shared by normal lymphocytes or by other leukemic cells. Agee JF; Garver FA; Faguet GB Blood; 1986 Jul; 68(1):62-8. PubMed ID: 2941085 [TBL] [Abstract][Full Text] [Related]
16. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers. Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211 [TBL] [Abstract][Full Text] [Related]
17. A comparison of membrane marker phenotypes in hairy-cell leukemia and phorbol-ester induced B-cll cells using monoclonal antibodies. Herrmann F; Dörken B; Ludwig WD; Schwarting R Leuk Res; 1985; 9(5):529-36. PubMed ID: 2409407 [TBL] [Abstract][Full Text] [Related]
18. Antigen presentation in an HLA-DR-restricted fashion by B-cell chronic lymphocytic leukemia cells. Yasukawa M; Shiroguchi T; Inatsuki A; Kobayashi Y Blood; 1988 Jul; 72(1):102-8. PubMed ID: 2455565 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies. Stöckbauer P; Malasková V; Soucek J; Chudomel V Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116 [TBL] [Abstract][Full Text] [Related]
20. Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation. Gazitt Y; Polliack A Blood Cells; 1987; 12(2):413-39. PubMed ID: 3497682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]